Synergy Pharmaceuticals Announces Plans to Initiate a Phase 2 Study of SP … – DailyFinance

Synergy Pharmaceuticals Announces Plans to Initiate a Phase 2 Study of SP … DailyFinance The only oral drug currently FDA approved to treat OIC in patients with chronic, non-cancer pain requires multiple daily dosing and it is not effective against methadone-related OIC. Pre-clinical data on SP-333 in an animal model of OIC will be … and more »

Methadone Treatment – Google News

Pain Management North – Methadone for Pain – Many people know that methadone is used to treat heroin addiction, but did you also know that it’s a very effective medication for the treatment of chronic p…

More Methadone Treatment Information…

Comments are closed.